Watching Parkinson's disease with wrist-based sensors.
Journal
NPJ digital medicine
ISSN: 2398-6352
Titre abrégé: NPJ Digit Med
Pays: England
ID NLM: 101731738
Informations de publication
Date de publication:
13 Jun 2022
13 Jun 2022
Historique:
received:
13
04
2022
accepted:
24
05
2022
entrez:
13
6
2022
pubmed:
14
6
2022
medline:
14
6
2022
Statut:
epublish
Résumé
Parkinson's disease (PD) lacks sensitive, objective, and reliable measures for disease progression and response. This presents a challenge for clinical trials given the multifaceted and fluctuating nature of PD symptoms. Innovations in digital health and wearable sensors promise to more precisely measure aspects of patient function and well-being. Beyond research trials, digital biomarkers and clinical outcome assessments may someday support clinician-initiated or closed-loop treatment adjustments. A recent study from Verily Life Sciences presents results for a smartwatch-based motor exam intended to accelerate the development and evaluation of therapies for PD.
Identifiants
pubmed: 35697864
doi: 10.1038/s41746-022-00619-4
pii: 10.1038/s41746-022-00619-4
pmc: PMC9192652
doi:
Types de publication
Editorial
Langues
eng
Pagination
73Informations de copyright
© 2022. The Author(s).
Références
Mov Disord. 2002 Jul;17(4):758-63
pubmed: 12210871
Sci Data. 2016 Mar 03;3:160011
pubmed: 26938265
NPJ Digit Med. 2021 Sep 3;4(1):129
pubmed: 34480109
Sensors (Basel). 2021 Apr 16;21(8):
pubmed: 33923809
NPJ Digit Med. 2022 May 23;5(1):65
pubmed: 35606508
BMC Neurol. 2019 Jul 17;19(1):160
pubmed: 31315608
Sci Transl Med. 2021 Feb 3;13(579):
pubmed: 33536284
J Parkinsons Dis. 2021;11(s1):S35-S47
pubmed: 33523020
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984